Approach to Lytic Bone Lesions

A lytic bone lesion — defined as an area of bone destruction visible on plain radiograph — is one of the most important and challenging findings in clinical orthopaedics. The differential diagnosis spans entirely benign, self-limiting lesions (non-ossifying fibroma, simple bone cyst) to aggressive primary malignancies (osteosarcoma, Ewing`s sarcoma) and metastatic carcinoma. The plain radiograph, interpreted systematically, remains the single most important initial investigation and is often diagnostic in isolation when read correctly. A structured radiological approach prevents the two cardinal errors: (1) over-investigating and over-treating a benign incidental lesion, and (2) missing or delaying the diagnosis of a malignant lesion.

• The orthopaedic oncology maxim: `don`t touch it until you know what it is`; the greatest risk in managing a bone lesion is proceeding to surgery — biopsy or excision — without a working diagnosis, without cross-sectional imaging, and without appropriate referral; an ill-planned biopsy in the wrong tissue plane contaminates surgical compartments and may convert a limb-salvageable lesion into one requiring amputation; the systematic radiological approach is the foundation of safe management
• The two questions that must be answered before any biopsy or intervention: (1) Is this lesion benign or potentially malignant? (2) What is the likely diagnosis based on the patient`s age, the lesion`s location, and its radiological features? Both questions can usually be answered from the plain radiograph and clinical context alone, with MRI and CT providing confirmation and staging detail

ZOT = zone of transition  |  NOF = non-ossifying fibroma  |  SBC = simple bone cyst  |  FD = fibrous dysplasia  |  GCT = giant cell tumour  |  ABC = aneurysmal bone cyst  |  EG = eosinophilic granuloma  |  Mets = metastasis

• Age is the most diagnostically powerful single variable in bone tumour interpretation; knowing the patient`s age alone can reduce a broad differential to a short list in most cases; the following age-based framework should be memorised: under 20 years — simple bone cyst (SBC), aneurysmal bone cyst (ABC), eosinophilic granuloma (Langerhans cell histiocytosis), non-ossifying fibroma (NOF), Ewing`s sarcoma (most common primary malignant bone tumour under 20), osteosarcoma (second decade); 20–40 years — giant cell tumour (GCT — characteristically skeletally mature patients aged 20–40, open physis is unusual), ABC, fibrous dysplasia; over 40 years — metastatic carcinoma is the most common cause of a lytic bone lesion in this age group (breast, lung, kidney, thyroid, prostate — remember `BLaKTP`); myeloma (peak 6th–7th decade); chondrosarcoma; lymphoma
• The rule for adults over 40: in any patient over 40 years presenting with a lytic bone lesion, metastatic carcinoma and myeloma MUST be excluded before considering any other diagnosis; even if the lesion has a benign-appearing radiological pattern, the prior probability of malignancy in this age group is so high that the index of suspicion must remain elevated; a full staging workup (CT chest-abdomen-pelvis, isotope bone scan, serum and urine protein electrophoresis for myeloma) is performed before biopsy
• Osteosarcoma: peak incidence in the second decade (10–20 years); second smaller peak in adults over 50 (secondary osteosarcoma — arising in Paget`s disease, previous irradiation, or pre-existing bone infarcts); distal femur, proximal tibia, proximal humerus — the `growth plate` equivalents; the most rapidly growing regions of the skeleton

• The zone of transition is the most reliable single radiological indicator of a lesion`s biological aggressiveness; it describes the interface between the lytic lesion and the surrounding normal bone; (1) Narrow ZOT (geographic/well-defined): a sharp demarcation between the lesion and normal bone; the lesion is growing slowly enough that the bone has time to react and create a defined sclerotic rim; a sclerotic border means benign or very slow-growing; (2) Moth-eaten: multiple poorly-defined holes in the bone — the lesion is growing faster than the bone can react; no clear border; suggests aggressive growth; seen in Ewing`s, lymphoma, myeloma, osteosarcoma; (3) Permeative: the most aggressive pattern; the lesion infiltrates between the trabeculae without destroying them en masse; the cortex appears normal but is riddled with microscopic tumour; the lesion has no discernible edge; characteristic of Ewing`s sarcoma and small-round-cell tumours
• Lodwick classification (grades I–III): Grade I = geographic/well-defined; Grade II = moth-eaten; Grade III = permeative; Grade III = highest aggression; Grade I can be sub-classified as IA (sclerotic rim), IB (no rim but well-defined), IC (poorly defined geographic)
• Clinical application: a lytic lesion with a narrow ZOT and complete sclerotic rim in a skeletally immature patient — very likely benign (NOF, SBC, fibrous dysplasia), can be managed with observation; a lytic lesion with a permeative ZOT and cortical breakthrough — requires urgent further investigation and specialist referral within 2 weeks

• Periosteal reaction occurs when the periosteum is lifted from the bone surface — either by tumour breaching the cortex (aggressive) or by a fracture (reactive); benign lesions do NOT produce an aggressive periosteal reaction unless there is a pathological fracture; (1) Solid (uniform) periosteal reaction — thick, wavy, well-formed new periosteal bone; seen in benign reactive states (stress fracture, osteomyelitis, benign tumours with pathological fracture); (2) Interrupted (aggressive) periosteal reaction — the periosteum is repeatedly lifted and broken by rapidly growing tumour; patterns include: Codman`s triangle (triangular elevation at the margin of the tumour = classic for osteosarcoma); sunburst (radial spicules of periosteal new bone = osteosarcoma); onion-skin (parallel lamellae of periosteal new bone = Ewing`s sarcoma)
• Codman`s triangle: the triangular area of periosteal elevation at the leading edge of a rapidly growing tumour; while classically described with osteosarcoma, it can occur with any aggressive tumour (Ewing`s, aggressive metastasis, osteomyelitis); it indicates aggression but is NOT pathognomonic of osteosarcoma alone
• Practical rule: any interrupted or aggressive periosteal reaction in the absence of a clear history of acute fracture or infection = assume aggressive bone tumour until proven otherwise

• The matrix of a bone lesion refers to the calcified material produced by the tumour cells visible within the lesion on plain X-ray; the pattern of mineralisation identifies the tissue of origin; (1) Chondroid matrix — arcs and rings pattern (`popcorn`, `lobular`, `C-shaped` calcifications); present in enchondroma, chondrosarcoma, osteochondroma, chondroblastoma; arcs-and-rings in an adult lytic lesion should raise the question of chondrosarcoma; (2) Osteoid (bone) matrix — `fluffy`, `cloud-like`, `cotton-wool` mineralisation produced directly by malignant osteoblasts; characteristic of osteosarcoma; (3) Ground-glass matrix — a hazy, homogeneous opacity; characteristic of fibrous dysplasia; (4) No matrix — a purely lytic lesion with no internal calcification; includes GCT, SBC, ABC, myeloma, metastases (RCC, thyroid — `blow-out` lytic)
• Combination features indicating malignancy: chondroid matrix + large size + cortical breakthrough + adult age = strongly suspicious for chondrosarcoma; osteoid matrix + Codman`s triangle + sunburst periosteal reaction + teenager = osteosarcoma until proven otherwise; any matrix pattern combined with a soft tissue mass = aggressive lesion requiring urgent referral

• Step A — MRI of the lesion: mandatory before biopsy for any lesion not confidently diagnosed as benign on plain X-ray; defines exact local extent (intramedullary extent, cortical breakthrough, soft tissue extension, neurovascular involvement, skip lesions); T1 defines medullary extent; T2/STIR reveals oedema, soft tissue involvement, and fluid-fluid levels (ABC); gadolinium enhancement characterises vascularity and solid vs cystic components; the MRI extent determines the biopsy approach and planned surgical margins
• Step B — CT chest, abdomen, pelvis (staging CT): for any lesion suspected of malignancy; identifies the primary tumour in metastatic disease; detects pulmonary metastases (osteosarcoma and Ewing`s metastasise to lung first — CT chest essential); identifies lymphadenopathy; assesses visceral primary in suspected metastatic disease
• Step C — Isotope bone scan: identifies multifocal disease (metastases, myeloma, polyostotic fibrous dysplasia, Paget`s); may be `cold` (photopenic) in myeloma; whole-body MRI increasingly preferred for myeloma staging
• Step D — Bloods: FBC; CRP/ESR (raised in Ewing`s — mimics osteomyelitis); ALP (markedly elevated in osteosarcoma and Paget`s); LDH (elevated in Ewing`s and lymphoma); SPEP + UPEP for myeloma; serum calcium; PSA (prostate mets); thyroid function; uric acid (lymphoma)
• Step E — Biopsy (last): performed AFTER all imaging reviewed; must be planned by the treating orthopaedic oncologist; biopsy tract must be in the line of the planned surgical incision (excised en bloc with tumour); a wrongly sited biopsy tract may necessitate amputation; core needle biopsy under CT/ultrasound guidance at the treating centre is the modern standard

• NICE 2-week-wait referral criteria (NG12): refer urgently to a bone tumour service if: (1) plain X-ray suggests primary bone sarcoma at any age; (2) unexplained bone pain or swelling in a child or young person; (3) adult with unexplained lytic lesion on X-ray; (4) patient over 40 with bone lesion and constitutional symptoms; (5) known primary malignancy with new bone pain — pathological fracture risk assessment required
• Impending pathological fracture — Mirels scoring system: site (upper limb 1, lower limb 2, peritrochanteric 3) + nature (blastic 1, mixed 2, lytic 3) + size (<1/3 cortex 1, 1/3–2/3 2, >2/3 3) + pain (mild 1, moderate 2, severe 3); score ≥9 = prophylactic fixation recommended; a lytic lesion destroying >50% of the cortex in a weight-bearing bone = urgent orthopaedic review

• 5-step X-ray approach: (1) Age; (2) Location (epi/meta/dia, central/eccentric); (3) ZOT (narrow = benign; permeative = aggressive); (4) Periosteal reaction (solid = benign; Codman`s/sunburst/onion-skin = malignant); (5) Matrix (chondroid arcs-rings; osteoid fluffy; ground-glass FD; no matrix = GCT/SBC/myeloma)
• Age rule: <20 = SBC, ABC, NOF, Ewing`s, osteosarcoma; 20–40 = GCT; >40 = ALWAYS exclude metastasis and myeloma first
• ZOT is the most reliable indicator of aggression: narrow sclerotic rim = benign; permeative (no edge, infiltrating trabeculae) = maximally aggressive (Ewing`s, small round cell tumours)
• Periosteal reactions: Codman`s triangle + sunburst = osteosarcoma; onion-skin = Ewing`s; any interrupted periosteal reaction = aggressive until proven otherwise
• Do NOT biopsy before MRI; do NOT biopsy before staging CT; biopsy must be planned by the treating oncological surgeon in the line of the planned surgical incision; a wrongly sited biopsy may mandate amputation
• Metastatic primaries `BLaKTP`: Breast, Lung, Kidney, Thyroid, Prostate; lytic = breast/lung/kidney/thyroid; sclerotic = prostate; kidney and thyroid = vascular `blow-out` lytic lesions (angioembolise before biopsy)
• Myeloma: SPEP + UPEP (BJP); bone scan may be COLD; whole-body MRI for staging; punched-out pepper-pot skull; M-protein spike on electrophoresis
• Mirels score ≥9: prophylactic fixation for impending pathological fracture; peritrochanteric = highest site score (3); >2/3 cortical destruction = score 3; rest pain = score 3
• NOF: eccentric cortical metaphyseal lesion with sclerotic border in adolescent = virtually pathognomonic; no biopsy; resolves spontaneously with skeletal maturity
• GCT: subarticular lytic lesion abutting articular surface in skeletally mature patient aged 20–40; NO sclerotic rim; distal femur, proximal tibia, distal radius; denosumab (anti-RANKL) for unresectable or recurrent GCT